Chevrolet J C
Div. pneumologie et soins intensifs médicaux, Hôpital cantonal universitaire, Genève.
Schweiz Rundsch Med Prax. 1990 May 29;79(22):694-7.
Methylxanthines are at present widely prescribed for obstructive airway-diseases. However, the exact therapeutic role of these drugs is not clear in 1990. In this short review, we discuss what we think to be a rational use of xanthines in asthma and in COPD patients: shortly speaking, we propose that the drugs are not first-line therapeutic tools and should be only prescribed in selected situations.
甲基黄嘌呤目前被广泛用于治疗阻塞性气道疾病。然而，在1990年，这些药物的确切治疗作用尚不清楚。在这篇简短的综述中，我们讨论了我们认为在哮喘和慢性阻塞性肺疾病（COPD）患者中合理使用黄嘌呤的方法：简而言之，我们建议这些药物并非一线治疗手段，仅应在特定情况下使用。
